The regulatory progression of BioFire Defense’s COVID-19 test was authorized for Emergency Use on March 23 by the U.S. Food and Drug Administration. The test is performed on the BioFire® FilmArray® instrument, present in many Department of Defense facilities with results reported about 50 minutes after a sample, a nasopharyngeal swab in transport medium, is loaded for analysis. (Photo courtesy of BioFire Defense)
| Date Taken: | 04.20.2020 |
| Date Posted: | 08.31.2020 11:45 |
| Photo ID: | 6334305 |
| VIRIN: | 200420-O-IE261-442 |
| Resolution: | 1280x853 |
| Size: | 151.74 KB |
| Location: | FORT DETRICK, MARYLAND, US |
| Web Views: | 26 |
| Downloads: | 3 |
This work, USAMMDA Selected to Manage Tier 1 Acquisition Program Funding for Three COVID-19 Response Efforts [Image 2 of 2], by Jeffrey Soares, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
USAMMDA Selected to Manage Tier 1 Acquisition Program Funding for Three COVID-19 Response Efforts
USAMMDA receives Army Superior Unit Award for pandemic response
No keywords found.
